Influence of Patents on Embryonic Stem Cells Research

References (39)

1. 1 Embryonic Stem Cell Lines Derived from Human Blastocysts [DOI]
2. 2 The Tragedy of the Anticommons: Property in the Transition from Marx to Markets [DOI]
3. 3 Innovation and Its Discontents: How Our Broken Patent System Is Endangering Innovation and Progress, and What to Do About It [DOI]
4. 4 Patent systems for encouraging innovation: Lessons from economic analysis [DOI]
5. 5 The influence of patent protection on firm innovation investment in manufacturing industries [DOI]
6. 6 When means become ends: considering the impact of patent strategy on innovation [DOI]
7. 7 The effect of patent laws on invention rates: Evidence from cross-country panels [DOI]
8. 8 Duality in Property: Commons and Anticommons [DOI]
9. 9 How to measure innovation? New evidence of the technology–growth linkage [DOI]
10. 10 The global stem cell patent landscape: implications for efficient technology transfer and commercial development [DOI]
11. 11 International Review of Law and Economics
12. 12 Patents and Innovation Counts as Measures of Regional Production of New Knowledge [DOI]
13. 13 The decision to patent, cumulative innovation, and optimal policy [DOI]
14. 14 New guidance on the patentability of embryonic stem cell patents in Europe [DOI]
15. 15 Patent litigation when innovation is cumulative [DOI]
16. 16 ErbB2 Induces Notch1 Activity and Function in Breast Cancer Cells [DOI]
17. 17 Challenges to Human Embryonic Stem Cell Patents [DOI]
18. 18 Patents for genetic inventions: a tool to promote technological advance or a limitation for upstream inventions? [DOI]
19. 19 Patenting human pluripotent cells: balancing commercial, academic and ethical interests [DOI]
20. 20 Embryonic Stem Cell Patents and Human Dignity [DOI]
21. 21 Patenting human genetic material: refocusing the debate [DOI]
22. 22 Property rights, collective sales and government intervention: averting a tragedy of the anticommons [DOI]
23. 23 Patenting, Morality and Human Embryonic Stem Cell Science: Bioethics and Cultural Politics in Europe [DOI]
24. 24 The Tragedy of the Commune: Learning from worst-case scenarios [DOI]
25. 25 Controversies over stem cell research [DOI]
26. 26 Industry waits for fallout from Cabilly [DOI]
27. 27 Genentech's Cabilly victory [DOI]
28. 28 Comment on the Tragedy of the Anticommons in Biomedical Research [DOI]
29. 29 Governing stem cell research in California and the USA: towards a social infrastructure [DOI]
30. 30 Trends in the Human Embryonic Stem Cell Patent Field [DOI]
31. 31 Embryonic stem cell research and respect for human life: philosophical and legal reflections.
32. 32 Global HIV/AIDS estimates—looking beyond the numbers [DOI]
33. 33 Centenary of the enactment of the United Kingdom’s Patents and Designs Act 1907 [DOI]
34. 34 US Stem Cell Research Policy [DOI]
35. 35 Do Formal Intellectual Property Rights Hinder the Free Flow of Scientific Knowledge? An Empirical Test of the Anti-Commons Hypothesis [DOI]
36. 36 International Journal of Industrial Organization
37. 37 Biotechnology Valuation: An Introductory Guide [DOI]
38. 38 Fresh hope for German stem-cell patent case [DOI]
39. 39 Regenerative medicine [DOI]

Cited by 0

No indexed citations yet.

Related research

• Therapeutic Effects of Neural and Other Diverse Pluripotent Stem Cells in Treating Various Neurological Disorders — shares topic coverage
• Stem Cells and Regenerative Medicine – A Review — shares topic coverage
• Intrapulmonary Administration of Autologous Bone Marrow Derived Mononuclear Cells in Congenital Heart Disease Complicated by Pulmonary Arterial Hypertension: A Case Report — shares topic coverage
• A Review of the Therapeutic Potentials of Stem Cells, Fibroblast Growth Factors and T-cells in Regenerative Medicine — shares topic coverage
• Stem Cell Diversity and Applications in Therapy — shares topic coverage